S&P 500   4,367.25
DOW   34,241.90
QQQ   360.24
3 ETFs for the Conservative Investor to Buy and Hold
How is This "Hidden Gem" Thriving in a Turbulent Market? (Ad)
Are These Consumer Staples Too Cheap for Investors To Ignore?
Stock market today: Wall Street poised for more losses after Fed says rates may stay high in '24
How is This "Hidden Gem" Thriving in a Turbulent Market? (Ad)
3 Reasons This Tech Giant Is Going Back To Highs
A small venture capital player becomes a symbol in the fight over corporate diversity policies
Is Gold Really Boring? (Ad)
Markets Are Loving These Stocks 'Firing On All Cylinders'
5 Reasons Why Amprius is About to Take Flight 
S&P 500   4,367.25
DOW   34,241.90
QQQ   360.24
3 ETFs for the Conservative Investor to Buy and Hold
How is This "Hidden Gem" Thriving in a Turbulent Market? (Ad)
Are These Consumer Staples Too Cheap for Investors To Ignore?
Stock market today: Wall Street poised for more losses after Fed says rates may stay high in '24
How is This "Hidden Gem" Thriving in a Turbulent Market? (Ad)
3 Reasons This Tech Giant Is Going Back To Highs
A small venture capital player becomes a symbol in the fight over corporate diversity policies
Is Gold Really Boring? (Ad)
Markets Are Loving These Stocks 'Firing On All Cylinders'
5 Reasons Why Amprius is About to Take Flight 
S&P 500   4,367.25
DOW   34,241.90
QQQ   360.24
3 ETFs for the Conservative Investor to Buy and Hold
How is This "Hidden Gem" Thriving in a Turbulent Market? (Ad)
Are These Consumer Staples Too Cheap for Investors To Ignore?
Stock market today: Wall Street poised for more losses after Fed says rates may stay high in '24
How is This "Hidden Gem" Thriving in a Turbulent Market? (Ad)
3 Reasons This Tech Giant Is Going Back To Highs
A small venture capital player becomes a symbol in the fight over corporate diversity policies
Is Gold Really Boring? (Ad)
Markets Are Loving These Stocks 'Firing On All Cylinders'
5 Reasons Why Amprius is About to Take Flight 
S&P 500   4,367.25
DOW   34,241.90
QQQ   360.24
3 ETFs for the Conservative Investor to Buy and Hold
How is This "Hidden Gem" Thriving in a Turbulent Market? (Ad)
Are These Consumer Staples Too Cheap for Investors To Ignore?
Stock market today: Wall Street poised for more losses after Fed says rates may stay high in '24
How is This "Hidden Gem" Thriving in a Turbulent Market? (Ad)
3 Reasons This Tech Giant Is Going Back To Highs
A small venture capital player becomes a symbol in the fight over corporate diversity policies
Is Gold Really Boring? (Ad)
Markets Are Loving These Stocks 'Firing On All Cylinders'
5 Reasons Why Amprius is About to Take Flight 
NASDAQ:HCAT

Health Catalyst (HCAT) Stock Forecast, Price & News

$10.61
+0.30 (+2.91%)
(As of 09/20/2023 ET)
Compare
Today's Range
$10.30
$10.74
50-Day Range
$10.31
$14.32
52-Week Range
$6.40
$15.87
Volume
444,862 shs
Average Volume
370,246 shs
Market Capitalization
$604.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.55

Health Catalyst MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.60 Rating Score
Upside/​Downside
37.1% Upside
$14.55 Price Target
Short Interest
Healthy
1.83% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.91
Upright™ Environmental Score
News Sentiment
-0.09mentions of Health Catalyst in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$73,600 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.93) to ($0.85) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.30 out of 5 stars

Medical Sector

316th out of 961 stocks

Computer Programming, Data Processing, & Other Computer Related Industry

22nd out of 59 stocks


HCAT stock logo

About Health Catalyst (NASDAQ:HCAT) Stock

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company offers data operating system data platform for analytics, and application development and interoperability that provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications designed to analyze the problems faced across clinical and quality, population health, and financial and operational use cases. It also provides services expertise, which include data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.

HCAT Price History

HCAT Stock News Headlines

Is Gold Really Boring?
Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks.
Is Gold Really Boring?
Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks.
Health Catalyst Reports Second Quarter 2023 Results
Steven Cohen Boosts Stake in Health Catalyst Inc
RBC Capital Sticks to Its Hold Rating for Health Catalyst (HCAT)
Health Catalyst (HCAT) Gets a Buy from Wells Fargo
Health Catalyst: Recovery Won't Be Soon
See More Headlines
Receive HCAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Health Catalyst and its competitors with MarketBeat's FREE daily newsletter.

HCAT Company Calendar

Last Earnings
8/08/2023
Today
9/21/2023
Next Earnings (Estimated)
11/14/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Computer programming, data processing, & other computer related
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:HCAT
Fax
N/A
Employees
1,200
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$14.55
High Stock Price Forecast
$18.00
Low Stock Price Forecast
$8.00
Forecasted Upside/Downside
+37.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.60
Research Coverage
10 Analysts

Profitability

Net Income
$-137,400,000.00
Pretax Margin
-51.63%

Debt

Sales & Book Value

Annual Sales
$276.24 million
Book Value
$7.76 per share

Miscellaneous

Free Float
55,425,000
Market Cap
$604.35 million
Optionable
Not Optionable
Beta
1.30
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Daniel D. BurtonMr. Daniel D. Burton (Age 48)
    CEO & Director
    Comp: $158.9k
  • Mr. Bryan Truman Hunt (Age 36)
    Chief Financial Officer
    Comp: $370.46k
  • Mr. Daniel H. OrensteinMr. Daniel H. Orenstein (Age 53)
    Sr. Advisor
    Comp: $356.56k
  • Mr. Kevin Freeman (Age 50)
    Chief Commercial Officer
    Comp: $405.9k
  • Ms. Anne Marie Bickmore (Age 60)
    COO & Chief Product Officer
  • Mr. Jason  AlgerMr. Jason Alger (Age 39)
    Chief Accounting Officer
  • Mr. Dave Ross
    Chief Technology Officer
  • Mr. Adam Brown
    Sr. VP of Investor Relations and Financial Planning & Analysis
  • Mr. Benjamin Landry
    Gen. Counsel & Sec. of the Board
  • Ms. Tarah Neujahr Bryan
    Chief Marketing & Communications Officer













HCAT Stock - Frequently Asked Questions

Should I buy or sell Health Catalyst stock right now?

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Health Catalyst in the last twelve months. There are currently 4 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" HCAT shares.
View HCAT analyst ratings
or view top-rated stocks.

What is Health Catalyst's stock price forecast for 2023?

10 brokerages have issued 12 month target prices for Health Catalyst's stock. Their HCAT share price forecasts range from $8.00 to $18.00. On average, they predict the company's share price to reach $14.55 in the next twelve months. This suggests a possible upside of 37.1% from the stock's current price.
View analysts price targets for HCAT
or view top-rated stocks among Wall Street analysts.

How have HCAT shares performed in 2023?

Health Catalyst's stock was trading at $10.63 at the beginning of the year. Since then, HCAT stock has decreased by 0.2% and is now trading at $10.61.
View the best growth stocks for 2023 here
.

When is Health Catalyst's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023.
View our HCAT earnings forecast
.

How were Health Catalyst's earnings last quarter?

Health Catalyst, Inc. (NASDAQ:HCAT) issued its earnings results on Tuesday, August, 8th. The company reported ($0.21) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.30) by $0.09. The company had revenue of $73.21 million for the quarter, compared to the consensus estimate of $72.67 million. Health Catalyst had a negative net margin of 51.76% and a negative trailing twelve-month return on equity of 16.49%.

What guidance has Health Catalyst issued on next quarter's earnings?

Health Catalyst issued an update on its third quarter 2023 earnings guidance on Tuesday, August, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $70.20 million-$74.20 million, compared to the consensus revenue estimate of $72.86 million.

What is Dan Burton's approval rating as Health Catalyst's CEO?

501 employees have rated Health Catalyst Chief Executive Officer Dan Burton on Glassdoor.com. Dan Burton has an approval rating of 99% among the company's employees. This puts Dan Burton in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 83.0% of employees surveyed would recommend working at Health Catalyst to a friend.

What other stocks do shareholders of Health Catalyst own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Health Catalyst investors own include NVIDIA (NVDA), Salesforce (CRM), Alteryx (AYX), Walt Disney (DIS), DocuSign (DOCU), Block (SQ), Slack Technologies (WORK), ServiceNow (NOW), Marvell Technology (MRVL) and PayPal (PYPL).

When did Health Catalyst IPO?

(HCAT) raised $129 million in an initial public offering on Thursday, July 25th 2019. The company issued 6,000,000 shares at $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and William Blair served as the underwriters for the IPO and Piper Jaffray, Evercore ISI, SVB Leerink and SunTrust Robinson Humphrey were co-managers.

What is Health Catalyst's stock symbol?

Health Catalyst trades on the NASDAQ under the ticker symbol "HCAT."

Who are Health Catalyst's major shareholders?

Health Catalyst's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (8.46%), Point72 Asset Management L.P. (4.21%), State Street Corp (2.49%), Goldman Sachs Group Inc. (2.20%), Dimensional Fund Advisors LP (2.14%) and Granahan Investment Management LLC (2.04%). Insiders that own company stock include Anita Pramoda, Benjamin Landry, Bryan Richard Hinton, Bryan Truman Hunt, D Fraser Bullock, Daniel D Burton, Daniel H Orenstein, Duncan Gallagher, James Patrick Jr Nelli, Jason Alger, Linda Llewelyn, Paul Horstmeier and Timothy G Ferris.
View institutional ownership trends
.

How do I buy shares of Health Catalyst?

Shares of HCAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Health Catalyst's stock price today?

One share of HCAT stock can currently be purchased for approximately $10.61.

How much money does Health Catalyst make?

Health Catalyst (NASDAQ:HCAT) has a market capitalization of $604.35 million and generates $276.24 million in revenue each year. The company earns $-137,400,000.00 in net income (profit) each year or ($2.68) on an earnings per share basis.

How many employees does Health Catalyst have?

The company employs 1,200 workers across the globe.

How can I contact Health Catalyst?

Health Catalyst's mailing address is 3165 MILLROCK DRIVE SUITE 400, SALT LAKE CITY UT, 84121. The official website for the company is www.healthcatalyst.com. The company can be reached via phone at (801) 708-6800 or via email at ir@healthcatalyst.com.

This page (NASDAQ:HCAT) was last updated on 9/21/2023 by MarketBeat.com Staff

My Account -